Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastrointest Oncol. Aug 15, 2014; 6(8): 263-274
Published online Aug 15, 2014. doi: 10.4251/wjgo.v6.i8.263
Published online Aug 15, 2014. doi: 10.4251/wjgo.v6.i8.263
Table 5 Complications of radiotherapy to esophagus and their management
Acute complications |
Skin erythema: 0.5% hydrocortisone, flamazine cream |
Hair loss: no treatment |
Mucositis, odynophagia, loss of appetite, fatigue, generalized weakness, dysphagia, dehydration, malnutrition, intestinal obstruction: intravenous hydration, xylocaine viscus, feeding tube |
Pneumonitis: prednisone, oxygen |
Spinal cord L'hermitte sign: no treatment |
Larynx hoarseness: prednisone |
Fistula/erosion of great vessels, esophageal perforation: consult thoracic surgeons |
Chronic complications |
Fibrosis/hyperpigmentation of skin: no treatment |
Lung fibrosis: oxygen |
Esophageal stricture: begins at 3-4 mo. Incidence: 50 Gy 0.8%, 60 Gy 0.6%; 60 Gy + chemo 12%. Treat by dilatation and/or stent |
Peptic ulcer: proton pump inhibitor |
Chronic enteritis: anti-diarrhoeal, aminosalicylates, pentoxifylline and tocopherol, cholestyramine, antibiotics, corticosteroids, hyperbaric oxygen |
Spinal cord myelopathy: hyperbaric oxygen, anticoagulation |
- Citation: Tai P, Yu E. Esophageal cancer management controversies: Radiation oncology point of view. World J Gastrointest Oncol 2014; 6(8): 263-274
- URL: https://www.wjgnet.com/1948-5204/full/v6/i8/263.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v6.i8.263